Periodic Reporting for period 1 - RIBORESCUEPHAGY (How does autophagy rescue stalled ribosomes?)
Okres sprawozdawczy: 2022-10-01 do 2025-03-31
Autophagy, a conserved cellular degradation pathway, plays a central role in recycling damaged or dysfunctional cellular components. While much is known about autophagy's role in general quality control, its involvement in resolving stalled ribosomes at the ER remains poorly understood. Recent discoveries in our lab have identified two key autophagy receptors, C53 and VCS, that mediate the clearance of harmful byproducts of ribosomal stalling. These findings suggest the existence of a novel quality control mechanism—RiboRescuePhagy—that rescues ER-bound ribosomes by selectively degrading stalled translation products.
The primary objective of this project is to unravel the molecular mechanisms and physiological significance of autophagy-mediated ribosomal rescue. Specifically, we aim to:
Characterize the role of C53 in degrading incomplete polypeptides that arise from ribosome stalling at the ER.
Investigate how VCS targets harmful RNAs generated during ribosome collisions and its dual function as an mRNA decapping regulator and autophagy receptor.
Elucidate the role of ufmylation, a specialized post-translational modification, in regulating these autophagy pathways.
This research integrates advanced genetic screens, structural biology, and biochemical approaches in both model plants (Arabidopsis and Marchantia) and human cells. By defining how autophagy maintains ER ribosome functionality, this project addresses a fundamental gap in our understanding of cellular quality control.
Expected Impact
The outcomes of this project will redefine our understanding of autophagy as a ribosome-associated quality control mechanism, with broad implications across eukaryotic biology. This knowledge is expected to inform therapeutic strategies for diseases linked to ER stress and ribosomal dysfunction, including neurodegenerative disorders and metabolic syndromes. Additionally, insights into RiboRescuePhagy could enhance biotechnological applications such as optimizing protein production in plants, a key tool for sustainable agriculture and pharmaceuticals.
We are progressing as we planned. Thanks to the support from the ERC, we have published 5 major publications. We are currently working on three more publications that will be submitted within the time frame of the proposal.
Brief summary of the main discoveries so far:
UFMylation and ER Homeostasis
Through phylogenomic and ribosome profiling studies, we uncovered a novel mechanism where UFMylation regulates mRNA export to alleviate ER stress. This process re-compartmentalizes and preserves translation of key mRNAs, thus reducing the translational load on the ER and promoting cellular resilience.
UFMylation and Epigenetics
Our research identified a unique subset of 24-nucleotide small RNAs whose biogenesis depends on UFMylation. These small RNAs regulate CG-type DNA methylation, providing new insights into the role of UFMylation in epigenetic regulation. These findings highlight a previously unexplored intersection of RNA processing and epigenetics.
Ribosome Heterogeneity in Pollen Cells
Initial translation assays revealed that pollen cells possess distinct ribosomal subunits compared to vegetative cells, resulting in unique translational dynamics. We utilized CryoEM to resolve the structures of these specialized ribosomes, offering a mechanistic understanding of their functional divergence. Ongoing analyses aim to link these structural differences to translational regulation in pollen.
CryoET and Cellular Reprogramming
Adopting Marchantia polymorpha as a model, we optimized CryoET pipelines to study spore dormancy and reprogramming. For the first time in plants, we visualized ribosomal structures in their native context, identifying factors responsible for maintaining ribosomal hibernation during spore dormancy. This breakthrough establishes CryoET as a powerful tool for studying cellular processes in plants at high resolution.
3 people from the lab also obtained independent PI positions, thanks to the ERC support.